KALEIDO BIOSCIENCES (KLDO) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 6 128 sessions, October 29, 2025 to October 29, 2026
- Largest daily move
- +4900% close of December 4, 2025
- 1-year change
- +0% closing prices, October 29, 2025 to October 29, 2026
- 1-month change
- +0% closing prices, September 25, 2026 to October 29, 2026
Company Description
KALEIDO BIOSCIENCES (OTC: KLDO) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $4.3K.
KLDO has gained 0.0% over the past year. The last closing price was $0.0001.
This page collects what Stock Titan holds for KLDO, including price data, latest news, and short interest trends.
Stock Performance
KALEIDO BIOSCIENCES (KLDO) closed at $0.0001 on October 29, 2026. Over the past 12 months, the price has gained 0.0%.
KLDO Metrics & Rankings
Price returns through October 29, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
KALEIDO BIOSCIENCES has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include conferences, earnings, clinical trial. View all KLDO news →
SEC Filings
Short Interest History
Short interest in KALEIDO BIOSCIENCES (KLDO) currently stands at 67.0 thousand shares, down 0.0% from the previous reporting period, representing 0.2% of the float.
Days to Cover History
Days to cover for KALEIDO BIOSCIENCES (KLDO) currently stands at 19.2 days, down 88.9% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has increased by 225.4%. Across the settlements charted above, it has ranged from 1.0 to 173.7 days.
KLDO Company Profile & Sector Positioning
KALEIDO BIOSCIENCES (KLDO) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing KLDO often look at related companies in the same sector, including ONCOLOGY PHARMA INC (ONPH), BETTER THERAPEUTICS INC (BTTX), REBUS HLDGS INC (RBSH), CARDAX INC (CDXI), and AMPIO PHARMS INC (AMPE). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate KLDO's relative position within its industry.